Walmart's Medicare Advantage tie-up with health insurer Scan tests whether trusted retailers can influence health choices without directly providing care.
The agency’s view on overall impressions is reaching beyond medical claims, which can lead to costly reworking or removal of creative for pharma brands.
Requiring prepayment may secure revenue for medical orgs, but unclear estimates and surprise charges damage the provider-patient relationship.
Old Navy Sport aims to strengthen the retailer’s authority in a competitive category.
While consumers are willing to pay cash for the pricey drugs, they’ll also come to expect the consistency in value of a premium purchase.
Health wearables have moved past step counting. They now offer personalized coaching, advanced health monitoring, and 24/7 conversational support. The technology is advancing faster than the answers to the questions it raises: whether the data is reliable, who can afford the devices, and whether doctors want the information at all. Modern devices now track complex health metrics including electrocardiograms to detect irregular heart rhythms, blood oxygen levels, skin temperature, heart rate variability, and stress levels. That is far beyond the basic step counting of earlier generations. "Wearables, of course, have been around for a while, but they're really having a moment this year," said our analyst Rajiv Leventhal on a recent episode of "Behind the Numbers."
The rebrand from Novo Nordisk to Novo supports its culture reset, but its pipeline and commercial progress matter far more.
Feeling encouraged to cut back on social media use may not translate into lasting behavior changes, especially when the warnings are easily dismissible.
Sanofi courts older pickleball players with COVID-19 vaccine campaign. But the company must overcome COVID-19 fatigue and waning interest in vaccination.
New social media and AI safeguards could set a national baseline for product design and data use.
Agents can connect strategy and execution as marketers target smaller patient and healthcare provider populations.
Apple's large health app user base and no added subscription for most new health features could give it an edge over rivals with similar offerings.
This voter perception aligns with the sectors’ consistently poor reputational ratings in other surveys, and puts more weight on transparency and accountability.
Default scheduling and reminders can take follow-up logistics off new mothers’ plates to close care delivery gaps.
Consistent, candid product information from healthcare and pharma brands can help physicians address health misinformation that leads patients to refuse care and treatment.
A pivotal trial miss could invite tougher questions about valuations and sales forecasts.
The drugs are changing how entire families eat, expanding their impact well beyond individual users.
Oura's health platform ambitions as outlined in its IPO filing could widen revenues, provided medical and wellness partners trust its data and guidance.
Mail-order pharmacies outperform stores digitally. Better online tools can ease medication access and strengthen retention.
In today’s podcast episode, we discuss the main takeaways from Meta’s landmark trial over kids and social media addiction, the safety features it plans to roll out, whether this makes a teen social media ban more or less likely, what we know about social media’s role in youth mental health, and what could change as a result of the settlement. Join Senior Director of Podcasts and host Marcus Johnson, along with Senior Analyst Beth Snyder Bulik and Analyst Marisa Jones. Listen wherever you get your podcasts, or watch on YouTube or Spotify.